|
Brenda, I wish I had your oncologist! I especially endorse his view about the usefulness of finding mets early.
Regarding the TM use, well this thread started with the actual statistics 69% & 76% which is pretty good. So if your onco says it has too many false well..this is the actual percentage.
However if you are a stage 1 or 2 and do not wish to worry yourself with these then it is your choice, there is no wrong or right answer as to how to handle your eveday life/anxiety post treatment and you know what? you have 70% or so to not need it! That said even if I was stage 1 or 2 I still would have TM because 30% risk or so he in my book worth considering. For me now it is the contrary seeing my TM low makes me smiles and lift me up..it does not stop worrying about symptomatic issues but I know that it helps me stay more cool.
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|